The document discusses various classes of anti-arrhythmic drugs, their mechanisms of action, therapeutic uses, and side effects. It covers class IA drugs like quinidine, procainamide, and disopyramide; class IB drugs like lidocaine, mexiletine, and tocainide; class IC drugs like flecainide, propafenone, and moricizine; class II beta blockers; class III potassium channel blockers like amiodarone, bretylium, and sotalol; and class IV calcium channel blockers. Common side effects include cardiac toxicity, arrhythmia exacerbation, hypotension, and gastrointestinal issues.